−0.0568USD
−9.93 MUSD
1.04 MUSD
135.51 M
About IntelGenx Technologies Corp.
Sector
CEO
Dwight Gorham
Headquarters
Ville Saint-Laurent
Website
Employees (FY)
57
Founded
1999
ISIN
US45822R1014
FIGI
BBG000BB7DD2
IntelGenx Technologies Corp. is a drug delivery company, which focuses on the development and manufacturing of pharmaceutical oral films based on its proprietary VersaFilm technology platform. Its products include rizaport, tadalafil, loxapine, and montelukast. The was founded on July 27, 1999 and is headquartered in Ville Saint-Laurent, Canada.
$IGXT Intelgenx Technologies Corp Golden cross buy signalIndicators bullish and signalling a reversal.
Golden cross on moving average.
Average analysts price target $1.17 | Buy rating
Company profile
IntelGenx Technologies Corp. is a oral drug delivery company, which focuses on the development and manufacturing of pharmaceutical oral films based on its p
Did IGXT Just Give It All Back?IGXT traded almost the same share volume as previous on Monday with a big red candle. Does this signal weakness for the stock and will it be able to hold levels at or above the previous gap it had from months prior?
"The biotech penny stock 's price increased by 61.5% over the month. It started w
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of IGXT is 0.17 USD — it has decreased by 8.16% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange IntelGenx Technologies Corp. stocks are traded under the ticker IGXT.
IntelGenx Technologies Corp. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for IntelGenx Technologies Corp. has a max estimate of 0.74 USD and a min estimate of 0.74 USD.
IGXT earnings for the last quarter are −0.01 USD whereas the estimation was −0.02 USD which accounts for 50.00% surprise. Estimated earnings for the next quarter are −0.02 USD. See more details about IntelGenx Technologies Corp. earnings.
IntelGenx Technologies Corp. revenue for the last quarter amounts to 510.00 K USD despite the estimated figure of 100.00 K USD. In the next quarter revenue is expected to reach 100.00 K USD.
Yes, you can track IntelGenx Technologies Corp. financials in yearly and quarterly reports right on TradingView.
Like other stocks, IGXT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IntelGenx Technologies Corp. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 16, 2024, the company has 57.00 employees. See our rating of the largest employees — is IntelGenx Technologies Corp. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. IntelGenx Technologies Corp. EBITDA is −8.73 M USD, and current EBITDA margin is −854.09%. See more stats in IntelGenx Technologies Corp. financial statements.